サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494477

欧州の医薬品販売受託機関：2030年市場予測-地域別分析-サービス、モジュール、治療領域、エンドユーザー別

Europe Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User
PrevNext
1
2
3
4

出版日
ページ情報
英文 88 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
欧州の医薬品販売受託機関：2030年市場予測-地域別分析-サービス、モジュール、治療領域、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 88 Pages
納期: 即納可能 即納可能とは
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の医薬品販売受託機関市場は、2022年の19億890万米ドルから2030年には34億7,497万米ドルに成長すると予測されています。2022～2030年のCAGRは7.8%を記録すると推定されます。

製薬会社の製品販売拡大への関心の高まりが欧州医薬品販売受託機関市場を牽引

近年、製薬会社は自社製品の販売を拡大するために革新的な戦略を採用するようになっています。こうした情勢の中で注目すべき動向のひとつは、製薬販売受託機関（CSO）への依存度が高まり、商業化努力の極めて重要な要素となっていることです。これは、製薬企業が市場の複雑さを乗り切るために積極的に取り組んでいることを物語っています。CSOを活用することで、製薬企業は専門的な営業力を活用し、外部からの熟練度を活用して市場への浸透を高め、販売実績を最適化することができます。この協業パラダイムにより、製薬企業は業務を効率化し、研究開発などのコアコンピタンスに集中することができ、同時にCSOの専門知識を活用して製品の市場での存在感を高めることができます。製薬企業とCSOの間のシナジー効果の高まりは、リソースの最適化に関する微妙な理解を反映しており、適応性へのコミットメントと、激しい競合情勢の中で進化する力学に対する鋭い認識を示しています。この共生関係は収益の最大化を促進し、持続的な成功のためには俊敏性と的を絞った市場戦略が最重要となる環境において、製薬企業を戦略的に位置づけています。

欧州医薬品販売受託機関市場概要

欧州の医薬品販売会社市場は、ドイツ、英国、フランス、イタリア、スペイン、その他の欧州に区分されます。この地域では、慢性疾患の急増、高齢者人口の増加、アンメットニーズを満たすための様々な治療用途の新薬分子に対する需要の増加により、医薬品需要が大幅に伸びています。ドイツには550社近くの製薬会社が進出しています。この国の医薬品販売受託機関（CSO）は、大手製薬会社や小規模バイオテクノロジー企業にサービスを提供し、欧州市場で主導的地位を獲得するための支援を行っています。ドイツ貿易投資庁のデータによると、ドイツにおける医薬品売上高は2020年に2019年比で6.7％増加し、607億9,000万米ドル（495億ユーロ）に達しました。ドイツをはじめとする欧州諸国の医薬品業界の情勢は、生物製剤の開発により最近の大きな変化を遂げています。その結果、生物製剤は、その強い治療的可能性により、医薬品事業のかなりの部分を占めるようになりました。大企業は現在、低分子医薬品の開発よりも、複雑な生物学的化合物の創出に集中しています。

2021年3月、IQVIAは Johnson & Johnsonの子会社であるヤンセンファーマシューティカルカンパニーの1つであるJanssen Research & Development, LLCと共同で、ヤンセンのCOVID-19ワクチンの第3相臨床試験に取り組みました。遠隔医療技術、バーチャル監視、デジタル患者対話戦術を組み合わせたこの臨床試験では、IQVIAの一連の分散型臨床試験ソリューションが活用され、オンサイトとリモート試験がサポートされました。IQVIAは、様々な顧客製品の上市とマーケティングに特化した世界最大のコマーシャルソリューション組織を有し、欧州各国に進出しています。

欧州医薬品販売受託機関市場の収益と2030年までの予測（金額）

欧州医薬品販売受託機関市場のセグメンテーション

欧州の医薬品販売受託機関市場は、サービス、モジュール、治療領域、エンドユーザー、国に区分されます。

サービス別では、欧州の医薬品販売受託機関市場は商用サービスと非商用サービスに二分されます。2022年の欧州医薬品販売受託機関市場では、商用サービスセグメントが大きなシェアを占めています。

モジュール別では、欧州医薬品販売受託機関市場は協調モジュールと専用モジュールに二分されます。2022年の欧州医薬品販売受託機関市場では、協調モジュールセグメントが大きなシェアを占めています。

治療セグメント別に見ると、欧州医薬品販売受託機関市場は、心血管疾患、がん、代謝疾患、神経学、整形外科疾患、感染症、その他に区分されます。2022年の欧州医薬品販売受託機関市場では、がんセグメントが最大のシェアを占めています。

エンドユーザー別に見ると、欧州医薬品販売受託機関市場はバイオ製薬企業と製薬会社に二分されます。製薬会社セグメントは2022年に欧州医薬品販売契約市場でより大きなシェアを占めました。

国別に見ると、欧州医薬品販売受託機関市場は、英国、ドイツ、フランス、スペイン、イタリア、その他の欧州に区分されます。2022年の欧州医薬品販売受託市場はドイツが独占。

Aenova Holding GmbH、IQVIA Holdings Inc、MaBico SA、Pfizer Inc、Syneos Health Incは、欧州の医薬品販売契約市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州医薬品販売受託機関の市場情勢

  • イントロダクション
  • PEST分析
    • 欧州PEST分析

第5章 欧州医薬品販売受託機関市場：主要産業力学

  • 市場促進要因
    • デジタル技術の統合の進展
    • 製薬会社の製品販売拡大への関心の高まり
  • 主要市場抑制要因
    • アウトソーシングに伴う品質問題
  • 主要市場機会
    • 遠隔医療と遠隔明細書作成の利用の増加
  • 今後の主要動向
    • 新興市場での拡大
  • 影響分析

第6章 医薬品販売受託機関市場：欧州市場分析

  • 欧州医薬品販売受託機関市場売上高、2022～2030年

第7章 欧州医薬品販売受託機関市場：サービス別収益と2030年までの予測

  • イントロダクション
  • 欧州医薬品販売受託機関市場、サービス別売上高シェア、2022年・2030年（%）
  • 商用サービス
  • 非商用サービス

第8章 欧州医薬品販売受託機関市場：モジュール別収益と2030年までの予測

  • イントロダクション
  • 欧州医薬品販売受託機関市場、モジュール別売上高シェア、2022年・2030年（%）
  • 協調モジュール
  • 専用モジュール

第9章 欧州医薬品販売受託機関市場：治療領域別収益と2030年までの予測

  • イントロダクション
  • 欧州医薬品販売受託機関市場、治療領域別売上高シェア、2022年・2030年（%）
  • 心血管疾患
  • がん
  • 代謝疾患
  • 神経学
  • 整形外科疾患
  • 感染症
  • その他

第10章 欧州医薬品販売受託機関市場：エンドユーザー別収益と2030年までの予測

  • イントロダクション
  • 欧州医薬品販売受託機関市場、エンドユーザー別売上高シェア、2022年・2030年（%）
  • バイオ製薬企業
  • 製薬企業

第11章 欧州医薬品販売受託機関市場：国別分析

  • 欧州医薬品販売受託機関市場：2030年までの収益と予測
      • 欧州医薬品販売受託機関市場：国別
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • その他の欧州

第12章 医薬品販売受託機関市場-業界情勢

  • イントロダクション
  • 成長戦略
    • 概要

第13章 企業プロファイル

  • MaBico SA
  • IQVIA Holdings Inc
  • Syneos Health Inc
  • Aenova Holding GmbH
  • Pfizer Inc

第14章 付録

図表

List Of Tables

  • Table 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation
  • Table 2. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
  • Table 27. Glossary of Terms, Europe Pharmaceutical Contract Sales Organizations Market

List Of Figures

  • Figure 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
  • Figure 2. Europe PEST Analysis
  • Figure 3. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • Figure 7. Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • Figure 10. Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • Figure 13. Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 21. Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 24. Europe Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00030018

The Europe pharmaceutical contract sales organizations market is expected to grow from US$ 1,908.90 million in 2022 to US$ 3,474.97 million by 2030. It is estimated to record a CAGR of 7.8% from 2022 to 2030.

Growing Interest of Pharmaceutical Companies to Increase Sales of Products Drives Europe Pharmaceutical Contract Sales Organizations Market

In recent years, pharmaceutical companies are increasingly adopting innovative strategies to augment the sales of their products. One notable trend within this landscape is the heightened reliance on pharmaceutical contract sales organizations (CSOs) as a pivotal component of their commercialization endeavors. This underscores a proactive approach by pharmaceutical entities to navigate the complexities of the market. By engaging CSOs, these companies can tap into specialized sales forces, capitalizing on external proficiency to enhance market penetration and optimize sales performance. This collaborative paradigm enables pharmaceutical firms to streamline their operations and concentrate on core competencies such as research and development while concurrently leveraging the tailored expertise of CSOs to bolster their products' market presence. The growing synergy between pharmaceutical companies and CSOs reflects a nuanced understanding of resource optimization, illustrating a commitment to adaptability and a keen awareness of the evolving dynamics within the fiercely competitive pharmaceutical landscape. This symbiotic relationship facilitates revenue maximization and positions pharmaceutical enterprises strategically in an environment where agility and targeted market strategies are paramount for sustained success.

Europe Pharmaceutical Contract Sales Organizations Market Overview

The European pharmaceutical contract sales organizations market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The demand for pharmaceutical products is growing significantly in this region with the burgeoning prevalence of chronic diseases, the rising geriatric population, and increasing demand for new drug molecules for various therapeutic applications to fulfill unmet needs. Nearly 550 pharmaceutical companies have operations in Germany. Contract sales organizations (CSOs) in this country provide their services to large pharmaceutical companies and small-scale biotech companies, assisting them in attaining leading positions in the European market. As per data by Germany Trade & Invest, pharmaceutical sales in Germany increased by 6.7% in 2020 compared to 2019, reaching US$ 60.79 billion (EUR 49.5 billion). The landscape of the pharmaceutical industry in Germany and other European countries has recently undergone significant changes due to the development of biological medications. As a result, biologics have taken up a sizeable portion of pharmaceutical businesses due to their strong therapeutic potential. Large corporations are now concentrating on creating complex biological compounds rather than developing small-molecule drugs.

In March 2021, IQVIA worked with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies, which is a subsidiary of Johnson & Johnson, on the Phase 3 clinical trials of Janssen's COVID-19 vaccine. Combining telehealth technologies, virtual oversight, and digital patient interaction tactics, the trials leveraged IQVIA's array of decentralized trial solutions, which were supported by on-site and remote studies. IQVIA has the world's largest commercial solutions organization dedicated to launching and marketing various clients' products, and the company has presence in various European countries.

Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

Europe Pharmaceutical Contract Sales Organizations Market Segmentation

The Europe pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the Europe pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on modules, the Europe pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the Europe pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on end user, the Europe pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on country, the Europe pharmaceutical contract sales organizations market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, IQVIA Holdings Inc, MaBico SA, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Europe pharmaceutical contract sales organizations market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Pharmaceutical Contract Sales Organizations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis

5. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Integration of Digital Technologies
    • 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
  • 5.2 Key Market Restraints
    • 5.2.1 Quality Issues Associated with Outsourcing
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Use of Telemedicine and Remote Detailing
  • 5.4 Key Future Trends
    • 5.4.1 Expansion in Emerging Markets
  • 5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Europe Market Analysis

  • 6.1 Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • 7.3 Commercial Services
    • 7.3.1 Overview
    • 7.3.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Commercial Services
    • 7.4.1 Overview
    • 7.4.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

  • 8.1 Overview
  • 8.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • 8.3 Syndicated Modules
    • 8.3.1 Overview
    • 8.3.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Dedicated Modules
    • 8.4.1 Overview
    • 8.4.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

  • 9.1 Overview
  • 9.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • 9.3 Cardiovascular Disorders
    • 9.3.1 Overview
    • 9.3.2 Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Oncology
    • 9.4.1 Overview
    • 9.4.2 Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Metabolic Disorders
    • 9.5.1 Overview
    • 9.5.2 Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Neurology
    • 9.6.1 Overview
    • 9.6.2 Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Orthopaedic Diseases
    • 9.7.1 Overview
    • 9.7.2 Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Infectious Diseases
    • 9.8.1 Overview
    • 9.8.2 Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Biopharmaceutical Companies
    • 10.3.1 Overview
    • 10.3.2 Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Pharmaceutical Contract Sales Organizations Market - Country Analysis

  • 11.1 Europe Pharmaceutical Contract Sales Organizations Market, Revenue and Forecast to 2030
      • 11.1.1.1 Europe Pharmaceutical Contract Sales Organizations Market, by Country
      • 11.1.1.2 UK
        • 11.1.1.2.1 UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.2.3 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.2.4 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.2.5 UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Germany
        • 11.1.1.3.1 Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.3.3 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.4 France
        • 11.1.1.4.1 France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 France: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.4.3 France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.4.4 France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.4.5 France: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.5 Italy
        • 11.1.1.5.1 Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.2 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.5.3 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.5.4 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.5.5 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.6 Spain
        • 11.1.1.6.1 Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.2 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.6.3 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.6.4 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.6.5 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.7 Rest of Europe
        • 11.1.1.7.1 Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.7.2 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.7.3 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.7.4 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.7.5 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 MaBico SA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 IQVIA Holdings Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Syneos Health Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Aenova Holding GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Pfizer Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms